Why the study?
Does paclitaxel-eluting balloon angioplasty prevent the composite of cardiac death, recurrent MI and TLR in patients presenting with ST-elevation MI?
Population
100 patients presenting with ST-elevation MI
Design
Cohort
Follow-up
one-year
Authors
Loading...
DCB angioplasty appears feasible in STEMI PPCI; leaves open whether it reduces events versus stenting in randomized trials.
Does paclitaxel-eluting balloon angioplasty prevent the composite of cardiac death, recurrent MI and TLR in patients presenting with ST-elevation MI?
A paclitaxel-eluting balloon angioplasty-only strategy in primary PCI for STEMI appears safe and feasible, with a 5% rate of major adverse cardiac events at one year.
Vos et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: